Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|February 5, 2016
Prevalence of Malignancies in Patients With Primary AldosteronismK Lang, K Weber, M Quinkler, et al.
FEBS Letters|July 12, 2024
Differential effects of the N-terminal helix of FGF8b on the activity of a small-molecule FGFR inhibitor in cell culture and for the extracellular domain of FGFR3c in solutionKonstantin S Mineev, Bruno Hargittay, Jing Jin, et al.
Infection Control and Hospital Epidemiology|December 7, 2018
Human factors-based risk analysis to improve the safety of doffing enhanced personal protective equipmentAyse P Gurses, Aaron S Dietz, Elaine Nowakowski, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 13, 2018
The metabolic capacity of lipid droplet localized acyl-CoA synthetase 3 is not sufficient to support local triglyceride synthesis independent of the endoplasmic reticulum in A431 cellsMargarete Poppelreuther, Simone Sander, Fadil Minden, et al.
Clinical Chemistry|January 21, 2016
Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary AldosteronismGraeme Eisenhofer, Tanja Dekkers, Mirko Peitzsch, et al.
Clinical and Experimental Immunology|January 23, 2016
Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantationC S Link, A Eugster, F Heidenreich, et al.
Advances in Radiation Oncology|April 14, 2020
Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade GliomasMatthew S Dietz, Catherine Z Beach, Ramon Barajas, et al.
Journal of the American Chemical Society|December 30, 2025
Fast, Bright, and Reversible Fluorescent Labeling of Rhodamine-Binding ProteinsJulian Kompa, Lars J Dornfeld, Nicola Porzberg, et al.
Cancer|August 25, 2024
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor BoardAjay Gupta, Matthew S Dietz, Richard F Riedel, et al.
Oncogene|June 9, 2021
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53Patrizia Malkomes, Ilaria Lunger, Elsie Oppermann, et al.
Pageof 13